Αρχειοθήκη ιστολογίου

Τρίτη 6 Μαρτίου 2018

Antisense oligonucleotide therapy for spinocerebellar ataxia type 2

Scoles, DR; Meera, P; Schneider, MD; Paul, S; Dansithong, W; Figueroa, KP; Hung, G; ... Pulst, SM; + view all Scoles, DR; Meera, P; Schneider, MD; Paul, S; Dansithong, W; Figueroa, KP; Hung, G; Rigo, F; Bennett, CF; Otis, TS; Pulst, SM; - view fewer (2017) Antisense oligonucleotide therapy for spinocerebellar ataxia type 2. Nature , 544 (7650) pp. 362-366. 10.1038/nature22044 . Green open access

http://ift.tt/2I5BQj3

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου